Sender Company & Partners’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-30,132
Closed -$438K 34
2021
Q4
$438K Buy
+30,132
New +$438K 0.22% 68